Discover 2,493 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,493
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
FeaturedActive & Responsive
Kegg Fertility Study
for
Fertility
Location: 1 recruiting location
Sponsor: Lady Technologies Inc
Sex: Female
Age: 18 - 40
Code: NCT06862440
Recruiting
Active & Responsive
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: 352 recruiting locations
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Active & Responsive
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
for
Osteoarthritis, Knee
Location: 5 recruiting locations
Sponsor: Nature Cell Co. Ltd.
Sex: All
Age: 18+
Code: NCT04368806
Phase2, Phase3, Recruiting
Active & Responsive
A PIVOTAL STUDY EVALUATING SAFETY and EFFICACY of the SHIRATRONICS MIGRAINE THERAPY SYSTEM
for
Headache Migraine Chronic
Location: 15 recruiting locations
Sponsor: ShiraTronics
Sex: All
Age: 22+
Code: NCT06167655
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
for
Asthma
Location: 114 recruiting locations
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 4+
Code: NCT06052267
Phase3, Recruiting
Active & Responsive
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
for
Non-small Cell Lung Cancer (NSCLC)
Location: 18 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06305754
Phase3, Recruiting
Active & Responsive
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
for
Degenerative Disc Disease
Location: 39 recruiting locations
Sponsor: Mesoblast, Ltd.
Sex: All
Age: 18+
Code: NCT06325566
Phase3, Recruiting
Active & Responsive
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions